Fiduciary Trust Co. cut its position in shares of Clorox Company (The) (NYSE:CLX) by 14.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,274 shares of the company’s stock after selling 536 shares during the period. Fiduciary Trust Co.’s holdings in Clorox Company (The) were worth $441,000 at the end of the most recent reporting period.
Several other hedge funds have also recently made changes to their positions in CLX. BlackRock Inc. raised its stake in Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock worth $1,400,912,000 after buying an additional 9,698,542 shares in the last quarter. Parnassus Investments CA bought a new stake in Clorox Company (The) during the first quarter worth $434,255,000. Vanguard Group Inc. raised its stake in Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock worth $1,909,829,000 after buying an additional 649,766 shares in the last quarter. Morgan Stanley raised its stake in Clorox Company (The) by 31.9% in the first quarter. Morgan Stanley now owns 996,369 shares of the company’s stock worth $134,342,000 after buying an additional 241,210 shares in the last quarter. Finally, WINTON GROUP Ltd raised its stake in Clorox Company (The) by 762.4% in the first quarter. WINTON GROUP Ltd now owns 228,197 shares of the company’s stock worth $28,566,000 after buying an additional 201,737 shares in the last quarter. Hedge funds and other institutional investors own 70.56% of the company’s stock.
Clorox Company (NYSE:CLX) traded down 0.18% during midday trading on Friday, hitting $134.49. 750,794 shares of the stock traded hands. Clorox Company has a one year low of $111.24 and a one year high of $141.76. The company has a market cap of $17.32 billion, a P/E ratio of 26.57 and a beta of 0.40. The company’s 50 day moving average is $134.79 and its 200-day moving average is $133.07.
Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. During the same period in the previous year, the business posted $1.30 earnings per share. The business’s revenue was up 2.9% compared to the same quarter last year. On average, equities research analysts forecast that Clorox Company will post $5.69 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 4th. Investors of record on Wednesday, July 19th were issued a dividend of $0.84 per share. The ex-dividend date of this dividend was Monday, July 17th. This represents a $3.36 dividend on an annualized basis and a yield of 2.50%. This is an increase from Clorox Company (The)’s previous quarterly dividend of $0.80. Clorox Company (The)’s payout ratio is currently 63.04%.
COPYRIGHT VIOLATION WARNING: This news story was first published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://stocknewstimes.com/2017/08/06/clorox-company-the-nyseclx-position-reduced-by-fiduciary-trust-co-updated-updated.html.
CLX has been the subject of a number of analyst reports. Citigroup Inc. upped their target price on Clorox Company (The) from $75.00 to $76.00 and gave the stock a “neutral” rating in a report on Friday, April 7th. Jefferies Group LLC started coverage on Clorox Company (The) in a research report on Tuesday, April 18th. They set a “hold” rating and a $138.00 price target on the stock. Vetr downgraded Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price target on the stock. in a research report on Tuesday, April 18th. Royal Bank Of Canada set a $115.00 price target on Clorox Company (The) and gave the stock a “hold” rating in a research report on Monday, April 24th. Finally, BMO Capital Markets reaffirmed a “buy” rating and set a $136.00 price target on shares of Clorox Company (The) in a research report on Thursday, May 4th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $129.13.
Clorox Company (The) Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.
